DE69824422D1 - Sterilisierte 5-aminolevulinsäure - Google Patents

Sterilisierte 5-aminolevulinsäure

Info

Publication number
DE69824422D1
DE69824422D1 DE69824422T DE69824422T DE69824422D1 DE 69824422 D1 DE69824422 D1 DE 69824422D1 DE 69824422 T DE69824422 T DE 69824422T DE 69824422 T DE69824422 T DE 69824422T DE 69824422 D1 DE69824422 D1 DE 69824422D1
Authority
DE
Germany
Prior art keywords
crystals
ala
colored
sterile
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69824422T
Other languages
English (en)
Other versions
DE69824422T2 (de
Inventor
Allyn Golub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dusa Pharmaceuticals Inc Canada
Dusa Pharmaceuticals Inc
Original Assignee
Dusa Pharmaceuticals Inc Canada
Dusa Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dusa Pharmaceuticals Inc Canada, Dusa Pharmaceuticals Inc filed Critical Dusa Pharmaceuticals Inc Canada
Publication of DE69824422D1 publication Critical patent/DE69824422D1/de
Application granted granted Critical
Publication of DE69824422T2 publication Critical patent/DE69824422T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of Radiation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
DE69824422T 1997-09-02 1998-09-02 Sterilisierte 5-aminolevulinsäure Expired - Lifetime DE69824422T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US921664 1997-09-02
US08/921,664 US5856566A (en) 1997-09-02 1997-09-02 Sterilized 5-aminolevulinic acid
PCT/US1998/018181 WO1999011604A1 (en) 1997-09-02 1998-09-02 Sterilized 5-aminolevulinic acid

Publications (2)

Publication Number Publication Date
DE69824422D1 true DE69824422D1 (de) 2004-07-15
DE69824422T2 DE69824422T2 (de) 2005-06-09

Family

ID=25445779

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824422T Expired - Lifetime DE69824422T2 (de) 1997-09-02 1998-09-02 Sterilisierte 5-aminolevulinsäure

Country Status (14)

Country Link
US (2) US5856566A (de)
EP (1) EP1007504B1 (de)
JP (1) JP2001514243A (de)
AT (1) ATE268748T1 (de)
AU (1) AU747730B2 (de)
BR (1) BR9812164A (de)
CA (1) CA2302228C (de)
DE (1) DE69824422T2 (de)
DK (1) DK1007504T3 (de)
ES (1) ES2223140T3 (de)
NO (1) NO327985B1 (de)
NZ (1) NZ503644A (de)
PT (1) PT1007504E (de)
WO (1) WO1999011604A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
FR2777782B1 (fr) * 1998-04-22 2001-05-18 Alexandre Marti Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
US6223071B1 (en) 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
DE19827417B4 (de) * 1998-06-19 2004-10-28 Hahn, Rainer, Dr.Med.Dent. Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
KR100365151B1 (ko) * 2000-05-08 2003-02-11 김형락 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도
KR100373147B1 (ko) * 2000-05-10 2003-02-25 김형락 스쿠치카충 감염증의 치료제
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
CZ295986B6 (cs) * 2000-07-28 2005-12-14 Science For Life, S. R. O. Příprava sterilních krystalů kyseliny 5-aminolevulové a jejich derivátů využitelných pro lékařské diagnostické a terapeutické účely
WO2002013788A1 (en) * 2000-08-16 2002-02-21 The General Hospital Corporation D/B/A Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
US6913615B2 (en) * 2002-03-25 2005-07-05 Lumerx, Inc. Chemiluminescent treatment of acne
EP1496994A4 (de) * 2002-04-02 2008-04-16 Lumerx Inc Gerät und verfahren unter verwendung von sichtbarem licht zur beschädigung und/oder vernichtung von mikroorganismen im körper
CA2479857A1 (en) * 2002-04-16 2003-10-30 Marc Joshua Tolkoff Chemiluminescent light source using visible light for biotherapy
US20050209330A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20060094781A1 (en) * 2004-11-04 2006-05-04 Syneron Medical Ltd. Method of treating extracellular matrix
CA2724949A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
CN109369433B (zh) * 2018-10-29 2020-01-17 庄晓青 一种f-18标记的5-氨基乙酰丙酸衍生物、合成方法及应用
MX2021014512A (es) * 2019-05-29 2022-02-11 Sonalasense Inc Sonosensibilizacion.
WO2023105290A1 (en) 2021-12-10 2023-06-15 Insightec, Ltd. Short-pulse sonodynamic treatment apparatus

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0685024B2 (ja) 1984-10-26 1994-10-26 オリンパス光学工業株式会社 内視鏡装置
JPS62111954A (ja) * 1985-11-09 1987-05-22 Japan Spectroscopic Co アミノレブリン酸の合成法
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
DE4228106A1 (de) 1992-08-24 1994-03-03 Medac Klinische Spezialpraep Verwendung von £-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
ES2160600T3 (es) 1992-09-21 2001-11-16 Quadra Logic Tech Inc Activacion transcutanea in vivo de agentes fotosensibles en la sangre.
JP2997979B2 (ja) * 1993-01-20 2000-01-11 株式会社コスモ総合研究所 ５−アミノレブリン酸の製造方法
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
JPH07238063A (ja) * 1994-02-25 1995-09-12 Cosmo Sogo Kenkyusho:Kk ５−アミノレブリン酸の回収精製法
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid

Also Published As

Publication number Publication date
BR9812164A (pt) 2000-07-18
AU747730B2 (en) 2002-05-23
NO327985B1 (no) 2009-11-02
AU9215598A (en) 1999-03-22
CA2302228C (en) 2011-10-25
ATE268748T1 (de) 2004-06-15
CA2302228A1 (en) 1999-03-11
JP2001514243A (ja) 2001-09-11
NZ503644A (en) 2002-09-27
PT1007504E (pt) 2004-10-29
WO1999011604A9 (en) 1999-07-08
ES2223140T3 (es) 2005-02-16
US6335465B1 (en) 2002-01-01
WO1999011604A1 (en) 1999-03-11
NO20001055L (no) 2000-04-18
DK1007504T3 (da) 2004-10-25
EP1007504A1 (de) 2000-06-14
US5856566A (en) 1999-01-05
DE69824422T2 (de) 2005-06-09
EP1007504B1 (de) 2004-06-09
NO20001055D0 (no) 2000-03-01

Similar Documents

Publication Publication Date Title
ATE268748T1 (de) Sterilisierte 5-aminolevulinsäure
BR0315088A (pt) Métodos para produção de um efeito antiangiogênico e/ou redutor de permeabilidade vascular em um animal de sangue quente e para tratamento de câncer em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6474 ou de um sal fermaceuticamento aceitável do mesmo e gencitabina
DE68922399D1 (de) Voraktivierte therapeutische agentien, hergeleitet von photoaktiven verbindungen.
DK1381611T3 (da) Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik
ES8200082A1 (es) Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina.
HU9202227D0 (en) Method for producing triazolo-pyrimidine derivatives and pharmaceutical preparatives containing said compounds
GB2222081A (en) Sterilising pharmaceutical formulations
BR0014895A (pt) Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais
DE3162614D1 (en) Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same
CA2270558A1 (en) Treatment of autoimmune diseases by photochemotherapy
RU92003144A (ru) Способ предотвращения деполимеризации растворов гиалуроновой кислоты при стерилизации ионизирующей радиацией
ES387801A1 (es) Metodo para la obtencion de cordones conductores para la regeneracion o renovacion de partes de tejido especificas des-truidas en el cuerpo humano y animal.
GB2120529A (en) Methods of preparing and using intravenous nutrient compositions
NO910033L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
ES2196165T3 (es) Terapia de citoxina activada por radiacion.
CN105770896A (zh) 含光敏分子组合物的光动力组合在痤疮治疗药物中的应用
RU2123364C1 (ru) Способ и устройство для лечения воспалительных процессов
EP0424667B1 (de) Salz, dessen ursprüngliche Farbe nach einer Verfärbung wiederhergestellt wurde, sowie ein Verfahren für diese Wiederherstellung
KR20210121826A (ko) 과산화수소를 산화반응시켜 발생한 물질을 당류와 혼재시켜 암조직에 주사하여 암세포를 괴사시키는 시스템
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
RU2104723C1 (ru) Способ воздействия на биологический объект световым потоком и устройство для его осуществления
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
Gomer et al. Examination of potentially lethal damage in cells treated with hematoporphyrin derivative and red light
RU93039070A (ru) Способ лечения больных местно-распространенными формами рака
RU93032381A (ru) Способ лечения хронического описторхоза

Legal Events

Date Code Title Description
8364 No opposition during term of opposition